Astrazeneca Pharma India logo

ASTRAZEN - Astrazeneca Pharma India Share Price

₹2626.7 -63.1  -2.4%

Last Trade - 10:15am

Sector
Healthcare
Size
Mid Cap
Market Cap £725.4m
Enterprise Value £699.2m
Revenue £88.3m
Position in Universe 283rd / 3172
Bullish
Bearish
Unlock ASTRAZEN Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ASTRAZEN Revenue Unlock ASTRAZEN Revenue

Net Income

ASTRAZEN Net Income Unlock ASTRAZEN Revenue

Normalised EPS

ASTRAZEN Normalised EPS Unlock ASTRAZEN Revenue

PE Ratio Range

ASTRAZEN PE Ratio Range Unlock ASTRAZEN Revenue

Dividend Yield Range

ASTRAZEN Dividend Yield Range Unlock ASTRAZEN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ASTRAZEN EPS Forecasts Unlock ASTRAZEN Revenue
Profile Summary

AstraZeneca Pharma India Limited is a global biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease. The Company operates through two segments: Healthcare and Clinical Trial. The Healthcare segment engages in the manufacture and sale of pharmaceutical products. The Clinical Trial segment renders clinical trial services on pharmaceutical products to its group companies. It has presence in over seven areas of healthcare, including diabetes, oncology, infection, local anesthesia and maternal healthcare. The principal products/services of the Company are Meronem and Brilinta/Axcer. Its pipeline includes products, such as AZD4076, MEDI6012, AZD2811, MEDI0680, selumetinib, anifrolumab and MEDI7510. Its brands include Crestor, Seloken XL, Meronem, Arimidex, Zoladex, Nexium and Brilinta.

Directors
Last Annual March 31st, 2019
Last Interim September 30th, 2019
Incorporated July 11, 1979
Public Since March 4, 2004
No. of Shareholders: 14,591
No. of Employees: 1,452
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange National Stock Exchange of India
Shares in Issue 25,000,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ASTRAZEN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ASTRAZEN
Upcoming Events for ASTRAZEN
Tuesday 4th February, 2020 Estimate
Q3 2020 Astrazeneca Pharma India Ltd Earnings Release
Similar to ASTRAZEN
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.